Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Gossamer Bio

GOSS

0.20670.78% ( +0.0016 )

Closed: Jul 29, 16:00:00 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Gossamer Bio jumps 10% in after-hours trading as Leerink upgrades to Outperform
US Stock Market Update·1 day ago, 04:32 PM
GOSS+0.78%
Gossamer Bio climbs 2% as Leerink upgrades to Outperform
US Stock Market Update·1 day ago, 12:50 PM
GOSS+0.78%
Gossamer Bio surges over 10% as Leerink upgrades to Outperform
US Stock Market Update·1 day ago, 09:10 AM
GOSS+0.78%
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga_article·1 day ago, 07:05 AM
ALT-2.34%OTLK+10.62%
This Honeywell Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
benzinga_article·1 day ago, 06:33 AM
CIB+0.45%GOSS+0.78%
Top Biotech Gainers: GOSS To File Seralutinib NDA In Sep, OMER Gains On AZN's Loss, FBRX Acquired
rttnews·2 days ago, 10:34 PM
FBRX-0.16%TVGNW-9.35%
12 Health Care Stocks Moving In Monday's After-Market Session
benzinga_article·2 days ago, 04:06 PM
RDHL-6.47%OPK-17.27%
Gossamer Bio | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 0
Earnings Watch·2 days ago, 03:03 PM
GOSS+0.78%
Gossamer Bio shares are trading higher after a pre‑NDA meeting and FDA minutes outlined a path to a September 2026 NDA filing for seralutinib in PAH. The company also regained global rights to the drug and won shareholder approval for a note exchange and reverse split to bolster its capital structure.
benzinga_article·2 days ago, 01:16 PM
GOSS+0.78%
Gossamer Bio Restructures Debt, Secures Full Control of Lead Drug Candidate
benzinga_article·2 days ago, 01:11 PM
GOSS+0.78%
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga_article·2 days ago, 12:06 PM
MPLT+22.01%PFSA-4.71%
Gossamer Bio shareholders approved convertible note exchange proposals at special meeting
PUBT·2 days ago, 06:03 AM
GOSS+0.78%
Gossamer Bio shareholders approve charter amendment increasing authorized common shares to 4 billion
PUBT·Jul 15 at 05:26 AM
GOSS+0.78%
Gossamer Bio sets initial warrant exercise price at $0.34 per share
PUBT·Jul 1 at 08:01 AM
GOSS+0.78%